Bernd Brust, President, Molecular Medicine at Life Technologies Corp (LIFE), sold 11,750 shares at $57.00 ($670K) on 2011-01-03, disclosed to the SEC on 2011-01-04.
Scheduled sale ($670k) by President, Molecular Medicine under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LIFE | SELL | 2011-01-03 | $350K | — | Filing → |
| LIFE | SELL | 2010-12-06 | $1.7M | — | Filing → |
| LIFE | SELL | 2010-03-02 | $611K | — | Filing → |